Llama-Derived Nanobodies Join the Fight Against Covid-19
Newly-launched Belgian startup ExeVir Bio will develop ‘nanobodies’ that bind very precisely to key areas…
July 30, 2020 - 3 minutes
Nanobodies
Belgian Biotech Raises €35M to Develop Eco-Friendly Pesticides
The Belgium-based company AgroSavfe has raised a Series C round of €35M to develop an…
July 30, 2019 - 2 minutes
Another One Gets Snapped Up: Ablynx has been Acquired by Sanofi for €3.9B
Sanofi will acquire Ablynx and get its hands on the biotech's exciting Nanobody technology just…
January 29, 2018 - 3 minutes
Edwin Moses on how Ablynx has made it to the top of European biotech
Ablynx CEO Edwin Moses discusses the technology and strategy that has led its company to…
December 11, 2017 - 8 minutes
Ablynx Launches $175M IPO on Wall Street After Phase III Success
Fresh from announcing positive Phase III results, Ablynx has wasted no time in filing a…
October 4, 2017 - 2 minutes
Belgian Biotech Breaks New Ground in Fight Against Life-Threatening Blood Disorder
Ablynx has triumphed where others have fallen by receiving positive Phase III results for the…
October 2, 2017 - 3 minutes
Dutch Biotech could treat Dyslipidemia with Belgian Nanobody
Argenx' partner Staten Biotechnology has published results that present a drug licensed from the Belgian…
August 23, 2017 - 1 minute
Sanofi Offers up to €2.4Bn to Belgian Biotech to Develop Nanobodies
Ablynx and Sanofi have entered a research collaboration and exclusive licensing agreement for up to…
July 20, 2017 - 1 minute
Merck to Pay Ablynx €15M for Getting a Second Nanobody ready for the Clinic
Ablynx is receiving its first milestone payment from a deal with Merck for the development…
May 23, 2017 - 2 minutes
Merck Outsources the Development of its Nanobody for Psoriasis
Merck has signed a new agreement with Avillion for its nanobody against psoriasis. Avillion will…
March 30, 2017 - 3 minutes
An Antibody to reduce Hospitalizations of Children starts Phase IIb trials
Ablynx has treated its first patient in a new trial targeting RSV infections, the main…
January 12, 2017 - 2 minutes
Llama Antibody Inhalation gets Positive Results for Respiratory Virus
Ablynx has gotten positive results for its candidate (ALX-0171) in Phase I/IIa trial for infants…
May 3, 2016 - 2 minutes
